Jordan’s Public Health and Surveillance Health Policies: During and After COVID-19 (Preprint)

2020 ◽  
Author(s):  
Raeda AlQutob ◽  
Musa Taha Ajlouni ◽  
Mohamed Majed Abu Farraj ◽  
Immanuel Azaad Moonesar
Keyword(s):  
Public Health ◽  
Health System ◽  
Health Financing ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Future Health ◽  
Health Crisis ◽  
Global Pandemic ◽  
Novel Coronavirus

UNSTRUCTURED In contemporary times, the wave of the novel Coronavirus disease (COVID-19) classified by the World Health Organisation as global pandemic has unravelled systems and processes including health, economic and social. In the case of the Kingdom of Jordan, the COVID-19 crisis illustrated for the need and ability of the policy making institutions and ministries to take many effective policies, initiatives and procedures that were met with marked approval as the opinion polls conducted by government and private institutions showed. The success of these interventions during the crisis calls upon the country’s health system to take advantage of this experience in the next stage of recovery and resilience to develop, maintain its sustainability, as well as the improvement of a number of hubs to assist the Kingdom in facing the challenges resulting from any future health crisis such as epidemics or natural disasters. The viewpoint interventions that are the most paramount given the current situation as public health evidence must inform activities in seven priority health system areas to manage during and after the pandemic includes factors on: (1) governance and management; (2) service delivery and research; (3) human resources; (4) health information systems; (5) technology and medicine; (6) health financing; and (7) citizens, refugees and communities.

scholarly journals The potential impact of COVID 19 on poor and conflict-ridden communities in Sub-Sahara Africa (SSA): A conceptual paper

2020 ◽  
Vol 1 (2) ◽  
pp. 125-132
Author(s):  
Mathew Nyashanu ◽  
Tistsi Tsopotsa ◽  
Scovia Nalugo Mbalinda ◽  
Gemma North ◽  
Maureen Mguni ◽  
...  
Keyword(s):  
Policy Development ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Public Health Professionals ◽  
Global Pandemic ◽  
Potential Impact ◽  
Wu Zhao ◽  
Future Policy ◽  
Novel Coronavirus

The first cases of the novel coronavirus disease (COVID-19), previously known as 2019-nCoV, were reported in late December 2019 in Wuhan, China (Wu, Zhao, Yu B, et al 2020). The virus then spread to Malaysia and Thailand and eventually to the Americas, Europe, Australia and Africa. On the 11thof March 2020 the World Health Organisation (WHO) declared the COVID-19 a global pandemic. This concept paper  explores the potential impact of COVID-19 on poverty stricken and conflict-ridden communities in Sub-Sahara Africa. In doing so, the paper also explored the implications for public health professionals working with these communities, including recommendation for future policy development.

scholarly journals A potential spice with multifunctional pharmacological properties can prevent COVID-19 disease

2021 ◽  
Vol 9 (6) ◽  
pp. 1840
Author(s):  
Subha Bose Banerjee
Keyword(s):  
Wide Spectrum ◽  
World Health Organisation ◽  
World Health ◽  
Replication Process ◽  
Health Crisis ◽  
Therapeutic Drugs ◽  
Global Pandemic ◽  
Therapeutic Properties ◽  
Novel Coronavirus ◽  
Pharmacologically Active

Novel coronavirus disease (COVID-19) is the major health crisis in the world. World Health Organisation has declared COVID-19 as a global pandemic. There are no effective drugs to treat COVID-19 infection. Till date include remdesivir, umifenovir, favipiravir, lopinavir/ritonavir, ribavirin, hydroxychloroquine, etc. are used to treat this disease. There is an urgent need for public health measures, not only to limit the spread of the virus, but also to implement preventive approaches to control severe COVID-19 disease. Most drugs on the market have shown unwanted symptoms and toxic effects related to these drugs. In this situation people are searching for safe herbal extracts and pharmacologically active molecules having numerous therapeutic properties. Garlic (Allium sativum L.; Family: Amaryllidaceae) is an aromatic herbaceous annual spice with numerous therapeutic properties. Garlic is one of the most efficient natural antibiotics against the wide spectrum of viruses and bacteria. Organosulfur (e.g. allicin and alliin) and flavonoid (e.g. quercetin) compounds are responsible for immunomodulatory effects of this healthy spice. The viral replication process is accelerated with the main structural protease of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). The formation of hydrogen bonds between this serine-type protease and garlic bioactives in the active site regions inhibits the COVID-19 outbreak. Intake of garlic and its derived-products in regular diet as an adjuvant therapy may minimise side effects and toxicity of the main therapeutic drugs of COVID-19 infection.

scholarly journals A cross-sectional study for determining the perception and preferences of immunity boosters for protection against COVID-19

2020 ◽  
Vol 7 (10) ◽  
pp. 1498
Author(s):  
Dhairya P. Nanavaty ◽  
Ankushi A. Sanghvi ◽  
Manav S. Mehta ◽  
Sarbari Gupta ◽  
Gurusharan Dumra
Keyword(s):  
Family Doctor ◽  
Drug Market ◽  
World Health Organisation ◽  
Cross Sectional Study ◽  
World Health ◽  
The Novel ◽  
Cross Sectional ◽  
Global Pandemic ◽  
Novel Coronavirus ◽  
Source Of Information

Background: The World Health Organisation declared the novel coronavirus (COVID-19) outbreak as a global pandemic on March 11, 2020.  The consumption of vitamins, especially C, D, and zinc, hydroxychloroquine, and Arsenicum album 30 (homeopathy), has increased tremendously. However, the clinical trial showing the benefits of these agents is still underway though there have been a lot of discussion about these in print, electronic, and social media.Method: A questionnaire-based observational study was conducted. The participants were inquired about the use of any type of immunity booster by them and the source of information regarding the same. The data was analysed using Excel and Python.Results: Our study included 1147 participants. A dramatic increase of 21.97% in the consumption of immunity-boosting agents after the COVID-19 outbreak was observed, maximally in Ayurveda. The major source of information for immunity-boosters was provided by friends/family/relatives (50.4%). 52.7% of the respondents selected Ayurveda as their preferred choice of immunity booster (prophylaxis). If the respondents were to develop any of the COVID-19 symptoms, the majority (45.1%) decided to contact their family doctor, and 53.7% chose Allopathy as their preferred system for treatment. 91.5% of the respondents agreed to take a vaccine if it develops.Conclusion: There has been a boom in the immunity booster drug market because people are selecting immunity boosters despite no scientific background. It is imperative to educate people regarding the same and also conduct research studies to find benefits, if any.

scholarly journals Pneumomediastinum in a child with severe COVID-19

2020 ◽  
pp. 20200062
Author(s):  
Anne G Carroll ◽  
Nuala Quinn ◽  
Carl Byrne ◽  
Ghadir Kassab ◽  
Siobhan Whelan ◽  
...  
Keyword(s):  
Health Care Providers ◽  
Clinical Course ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Care Providers ◽  
Radiological Findings ◽  
Global Pandemic ◽  
International Data ◽  
Novel Coronavirus

The current global pandemic of the novel coronavirus SARS-CoV2 is a threat to the health and lives of millions of people worldwide. The latest statistics from the World Health Organisation show that there have been 6,515,796 confirmed cases worldwide with 387,298 confirmed deaths (last update 5 June 2020, 10:41 CEST). The majority of critically unwell patients with SARS-CoV2 are adults and the radiological findings associated with them are consistent throughout the literature. However, the reported paediatric cases are few, and as such, there is a limited body of evidence available. More international data is needed, not only on the clinical presentation, but also the radiological findings, so that health-care providers are better able to understand and diagnose this pandemic disease. We describe a case of a previously healthy 9-year-old female who presented to the Emergency Department with symptoms suggestive of raised intracranial pressure. Her CT revealed a medulloblastoma and post-operatively she tested positive for SARS-CoV2. She had a rapid deterioration in her clinical condition and required admission to the intensive care unit (ICU). We provide the supporting radiology along her clinical course in order to demonstrate important insights into this disease in children, including the unusual pnemomediastinum complications which occurred as part of her clinical course. This case is the first reported of its kind.

Tackling COVID-19 Using Blockchain Technology

2021 ◽  
pp. 75-93
Author(s):  
Padmavathi U. ◽  
Narendran Rajagopalan
Keyword(s):  
Virus Disease ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Health Crisis ◽  
Record Keeping ◽  
The Public ◽  
Blockchain Technology ◽  
Novel Virus ◽  
Novel Coronavirus

In December 2019, the outbreak of novel coronavirus disease was first reported in Wuhan City, the capital of Hubei Province, China, and the virus started to exacerbate throughout the world. This new world health crisis threatens the public with its ongoing pandemic across the globe. This chapter first discusses the novel coronavirus disease (COVID-19) pandemic, symptoms and its preventive measures. A timeline of this virus disease by World Health Organisation (WHO) is depicted in this chapter. The authors enlighten the global impact of coronavirus on healthcare systems and the need for technology-empowered solutions to control the spread of this novel virus. In particular, this chapter focuses on the pioneering blockchain technology that has the potential to mitigate and fight against this pandemic outbreak. In addition, this chapter manifests how this distributed record keeping technology and its enriched features could help the healthcare professionals to combat the crisis.

scholarly journals SARS COV 2: Complete Review on Global Pandemic (Covid 19)

2020 ◽  
pp. 62-69
Author(s):  
Praveen Kumar Gupta ◽  
B. S. Rithu ◽  
Kauser Banu ◽  
A. Shruthi ◽  
C. Sahana
Keyword(s):  
Public Health ◽  
The Novel ◽  
Health Crisis ◽  
Public Health Crisis ◽  
Corona Virus ◽  
Global Pandemic ◽  
First Case ◽  
Life Threatening ◽  
Novel Coronavirus ◽  
Threatening Situation

SARS COV 2 (severe acute respiratory syndrome corona virus 2) has created a global health emergency worldwide due to public health crisis and life-threatening situation. According to a recent study it has been reported that the virus was found originated in animal and transmitted to humans through a food chain. First case was reported in Wuhan-china on December 2019, In this review we have enlightened on different aspects of novel coronavirus 2019 and measure to combat the battle against the novel corona virus 2019.

Comparative docking of SARS-CoV-2 receptors antagonists from repurposing drugs

2020 ◽  
Author(s):  
Micael Davi Lima de Oliveira ◽  
Kelson Mota Teixeira de Oliveira
Keyword(s):  
World Health Organisation ◽  
World Health ◽  
Lung Cells ◽  
The Novel ◽  
High Modulation ◽  
Main Protease ◽  
The World ◽  
Novel Coronavirus ◽  
Viral Receptors ◽  
Theoretical Results

According to the World Health Organisation, until 16 June, 2020, the number of confirmed and notified cases of COVID-19 has already exceeded 7.9 million with approximately 434 thousand deaths worldwide. This research aimed to find repurposing antagonists, that may inhibit the activity of the main protease (Mpro) of the SARS-CoV-2 virus, as well as partially modulate the ACE2 receptors largely found in lung cells, and reduce viral replication by inhibiting Nsp12 RNA polymerase. Docking molecular simulations were performed among a total of 60 structures, most of all, published in the literature against the novel coronavirus. The theoretical results indicated that, in comparative terms, paritaprevir, ivermectin, ledipasvir, and simeprevir, are among the most theoretical promising drugs in remission of symptoms from the disease. Furthermore, also corroborate indinavir to the high modulation in viral receptors. The second group of promising drugs includes remdesivir and azithromycin. The repurposing drugs HCQ and chloroquine were not effective in comparative terms to other drugs, as monotherapies, against SARS-CoV-2 infection.

scholarly journals Viability of Bacillus subtilis Cells in Airborne Bioaerosols on Face Masks

Atmosphere ◽  
2021 ◽  
Vol 12 (11) ◽  
pp. 1496
Author(s):  
Eun-Hee Lee ◽  
Yunsoo Chang ◽  
Seung-Woo Lee
Keyword(s):  
Bacillus Subtilis ◽  
World Health ◽  
The Novel ◽  
Fine Dust ◽  
Health Crisis ◽  
Viable Cells ◽  
Mask Material ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Sand Dust

The coronavirus disease 2019 (COVID-19) pandemic is a general health crisis and has irreversible impacts on human societies. Globally, all people are at risk of being exposed to the novel coronavirus through transmission of airborne bioaerosols. Public health actions, such as wearing a mask, are highly recommended to reduce the transmission of infectious diseases. The appropriate use of masks is necessary for effectively preventing the transmission of airborne bioaerosols. The World Health Organization (WHO) suggests washing fabric masks or throwing away disposable masks after they are used. However, people often use masks more than once without washing or disposing them. The prolonged use of a single mask might—as a result of the user habitually touching the mask—promote the spread of pathogens from airborne bioaerosols that have accumulated on the mask. Therefore, it is necessary to evaluate how long the living components of bioaerosols can be viable on the masks. Here, we evaluated the viability of airborne Bacillus subtilis (B. subtilis) in bioaerosols filtered on woven and anti-droplet (non-woven) face masks. As a simulation of being simultaneously exposed to sand dust and bioaerosols, the viability rates of bioaerosols that had accumulated on masks were also tested against fine dust and airborne droplets containing bacteria. The bioaerosols survived on the masks immediately after the masks were used to filter the bioaerosols, and the bacteria significantly proliferated after one day of storage. Thereafter, the number of viable cells in the filtered bioaerosols gradually decreased over time, and the viability of B. subtilis in bioaerosols on the masks varied, depending on the mask material used (woven or non-woven). Despite the reduction in viability, bioaerosols containing living components were still found in both woven and anti-droplet masks even after six days of storage and it took nine days not to have found them on masks. The number of viable cells in bioaerosols on masks significantly decreased upon exposure of the masks to fine dust. The results of this study should provide useful information on how to appropriately use masks to increase their duration of effectiveness against bioaerosols.

scholarly journals The Impact of Covid-19 Public Health Policies on Persons with Disability and their Caregivers in Malta

2021 ◽  
Vol 4 (2) ◽  
pp. 25-37
Author(s):  
Andrew Camilleri ◽  
Samantha Pace Gasan ◽  
Andrew Azzopardi
Keyword(s):  
Public Health ◽  
World Health Organisation ◽  
World Health ◽  
Persons With Disabilities ◽  
Health Authorities ◽  
Essential Services ◽  
Public Health Authorities ◽  
Novel Coronavirus ◽  
Restrictive Measures ◽  
The Impact

On March 11, 2020, the World Health Organisation (WHO) declared a global health pandemic, due to the spread of a novel coronavirus, later named “Covid-19”. The spread of Covid-19 led to social isolation, distancing and a number of restrictive measures in Malta.  The aim of this paper is to analyse the impact of Covid-19 and the subsequent restrictive measures on persons with disability and their caregivers and families in Malta. Using thematic analysis, the study found that a variety of impacts ranging from a sense of isolation, lack of essential services being provided, additional difficulties encountered at the place of work and education and measures that were not sufficiently tailored for persons with disability issued by public health authorities. Underlying the additional difficulties brought about by Covid-19, structural difficulties to access essential services as well as ignorance from policy makers and politicians and the added “vulnerable-ization” of persons with disabilities were found to be highly impacting factors that pervade the experience of persons with disabilities and their caregivers.

Curating the Evidence About COVID-19 for Frontline Public Health and Clinical Care: The Novel Coronavirus Research Compendium

2021 ◽  
pp. 003335492110587
Author(s):  
Andrew D. Redd ◽  
Lauren S. Peetluk ◽  
Brooke A. Jarrett ◽  
Colleen Hanrahan ◽  
Sheree Schwartz ◽  
...  
Keyword(s):  
Public Health ◽  
Clinical Care ◽  
The United States ◽  
The Novel ◽  
Health Crisis ◽  
The Public ◽  
Successful Model ◽  
Medical Response ◽  
Public Consumption ◽  
Novel Coronavirus

The public health crisis created by the COVID-19 pandemic has spurred a deluge of scientific research aimed at informing the public health and medical response to the pandemic. However, early in the pandemic, those working in frontline public health and clinical care had insufficient time to parse the rapidly evolving evidence and use it for decision-making. Academics in public health and medicine were well-placed to translate the evidence for use by frontline clinicians and public health practitioners. The Novel Coronavirus Research Compendium (NCRC), a group of >60 faculty and trainees across the United States, formed in March 2020 with the goal to quickly triage and review the large volume of preprints and peer-reviewed publications on SARS-CoV-2 and COVID-19 and summarize the most important, novel evidence to inform pandemic response. From April 6 through December 31, 2020, NCRC teams screened 54 192 peer-reviewed articles and preprints, of which 527 were selected for review and uploaded to the NCRC website for public consumption. Most articles were peer-reviewed publications (n = 395, 75.0%), published in 102 journals; 25.1% (n = 132) of articles reviewed were preprints. The NCRC is a successful model of how academics translate scientific knowledge for practitioners and help build capacity for this work among students. This approach could be used for health problems beyond COVID-19, but the effort is resource intensive and may not be sustainable in the long term.

Sign in / Sign up

Export Citation Format

Share Document